MENU
+Compare
ANIK
Stock ticker: NASDAQ
AS OF
Nov 28 closing price
Price
$9.88
Change
+$0.10 (+1.02%)
Capitalization
142.48M

ANIK Anika Therapeutics Forecast, Technical & Fundamental Analysis

Anika Therapeutics Inc is an orthopedic medicines company... Show more

ANIK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ANIK with price predictions
Nov 28, 2025

Aroon Indicator for ANIK shows an upward move is likely

ANIK's Aroon Indicator triggered a bullish signal on November 14, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 162 similar instances where the Aroon Indicator showed a similar pattern. In of the 162 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where ANIK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ANIK moved above its 50-day moving average on November 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIK advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

ANIK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for ANIK moved out of overbought territory on October 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIK as a result. In of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANIK turned negative on November 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ANIK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.971) is normal, around the industry mean (16.613). P/E Ratio (10.707) is within average values for comparable stocks, (73.373). ANIK's Projected Growth (PEG Ratio) (3.800) is slightly higher than the industry average of (1.953). ANIK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.262) is also within normal values, averaging (55.744).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
ANIK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANIK is expected to report earnings to fall 437.50% to -13 cents per share on March 10

Anika Therapeutics ANIK Stock Earnings Reports
Q4'25
Est.
$-0.14
Q3'25
Beat
by $0.22
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.20
The last earnings report on November 05 showed earnings per share of 3 cents, beating the estimate of -18 cents. With 68.24K shares outstanding, the current market capitalization sits at 142.48M.
A.I. Advisor
published General Information

General Information

a manufacturer of commercializes therapeutic products for tissue protection, healing and repair

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
32 Wiggins Avenue
Phone
+1 781 457-9000
Employees
357
Web
https://www.anika.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SASOF6.90N/A
N/A
Sasol Ltd.
BPTSY2.00N/A
N/A
Biophytis SA
ADLRF13.74N/A
N/A
ALARIS EQUITY PARTNERS INCOME TR
AWCA0.14N/A
N/A
Awaysis Capital Inc.
SIGGF2.13N/A
N/A
Sigma Healthcare Limited

ANIK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with RVTY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
+1.02%
RVTY - ANIK
39%
Loosely correlated
-0.24%
ORGO - ANIK
36%
Loosely correlated
-4.43%
AVNS - ANIK
35%
Loosely correlated
-0.84%
ACRS - ANIK
34%
Loosely correlated
-1.74%
FLGT - ANIK
32%
Poorly correlated
-1.89%
More

Groups containing ANIK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
+1.02%
Pharmaceuticals
category (377 stocks)
37%
Loosely correlated
+0.36%
Pharmaceuticals: Generic
category (213 stocks)
35%
Loosely correlated
+0.54%